Design, synthesis and biological evaluation of a new class of 7H-pyrrolo[2,3-d]pyrimidine derivatives as Mps1 inhibitors for the treatment of breast cancer

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 71, 209, 10.3322/caac.21660 Ji, 2019, Chemoresistance mechanisms of breast cancer and their countermeasures, Biomed. Pharmacother., 114, 10.1016/j.biopha.2019.108800 Ji, 2018, Direct interactions of mitotic arrest deficient 1 (MAD1) domains with each other and MAD2 conformers are required for mitotic checkpoint signaling, J. Biol. Chem., 293, 484, 10.1074/jbc.RA117.000555 Mattison, 2007, Mps1 activation loop autophosphorylation enhances kinase activity, J. Biol. Chem., 282, 30553, 10.1074/jbc.M707063200 Tyler, 2009, Phosphoregulation of human Mps1 kinase, Biochem. J., 417, 173, 10.1042/BJ20081310 Wang, 2009, Structural and mechanistic insights into Mps1 kinase activation, J. Cell Mol. Med., 13, 1679, 10.1111/j.1582-4934.2008.00605.x Jelluma, 2008, Chromosomal instability by inefficient Mps1 auto-activation due to a weakened mitotic checkpoint and lagging chromosomes, PLoS One, 3, 10.1371/journal.pone.0002415 Jelluma, 2008, Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment, Cell, 132, 233, 10.1016/j.cell.2007.11.046 Fisk, 2003, Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression, Proc. Natl. Acad. Sci. U. S. A., 100, 14875, 10.1073/pnas.2434156100 Kasbek, 2007, Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells, Mol. Biol. Cell, 18, 4457, 10.1091/mbc.e07-03-0283 Leng, 2006, MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability, Proc. Natl. Acad. Sci. U. S. A., 103, 11485, 10.1073/pnas.0601828103 Dominguez-Brauer, 2015, Targeting mitosis in cancer: emerging strategies, Mol. Cell, 60, 524, 10.1016/j.molcel.2015.11.006 El Yakoubi, 2017, Mps1 kinase-dependent Sgo2 centromere localisation mediates cohesin protection in mouse oocyte meiosis I, Nat. Commun., 8, 694, 10.1038/s41467-017-00774-3 Liu, 2012, The MPS1 family of protein kinases, Annu. Rev. Biochem., 81, 561, 10.1146/annurev-biochem-061611-090435 Mattison, 2011, Mip1 associates with both the Mps1 kinase and actin, and is required for cell cortex stability and anaphase spindle positioning, Cell Cycle, 10, 783, 10.4161/cc.10.5.14955 Wei, 2005, TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68, J. Biol. Chem., 280, 7748, 10.1074/jbc.M410152200 Maachani, 2015, Targeting MPS1 enhances radiosensitization of human glioblastoma by modulating DNA repair proteins, Mol. Cancer Res., 13, 852, 10.1158/1541-7786.MCR-14-0462-T Xie, 2017, Mps1/TTK: a novel target and biomarker for cancer, J. Drug Target., 25, 112, 10.1080/1061186X.2016.1258568 Daniel, 2011, High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells, Proc. Natl. Acad. Sci. U. S. A., 108, 5384, 10.1073/pnas.1007645108 Kilpinen, 2010, Analysis of kinase gene expression patterns across 5681 human tissue samples reveals functional genomic taxonomy of the kinome, PLoS One, 5, 10.1371/journal.pone.0015068 Ling, 2014, Overexpression of Mps1 in colon cancer cells attenuates the spindle assembly checkpoint and increases aneuploidy, Biochem. Biophys. Res. Commun., 450, 1690, 10.1016/j.bbrc.2014.07.071 Suda, 2007, Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy, Cancer Sci., 98, 1803, 10.1111/j.1349-7006.2007.00603.x Atrafi, 2021, A Phase I study of an MPS1 inhibitor (BAY 1217389) in combination with paclitaxel using a novel randomized continual reassessment method for dose escalation, Clin. Cancer Res., 27, 6366, 10.1158/1078-0432.CCR-20-4185 Schulze, 2020, Treating cancer by spindle assembly checkpoint abrogation: discovery of two clinical candidates, BAY 1161909 and BAY 1217389, targeting MPS1 kinase, J. Med. Chem., 63, 8025, 10.1021/acs.jmedchem.9b02035 Woodward, 2018, J. Med. Chem., 61, 8226, 10.1021/acs.jmedchem.8b00690 Anderhub, 2019, High proliferation rate and a compromised spindle assembly checkpoint confers sensitivity to the MPS1 inhibitor BOS172722 in triple-negative breast cancers, Mol. Cancer Therapeut., 18, 1696, 10.1158/1535-7163.MCT-18-1203 Mason, 2017, Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer, Proc. Natl. Acad. Sci. U. S. A., 114, 3127, 10.1073/pnas.1700234114 Liu, 2016, Discovery of pyrazolo[1,5-a]pyrimidine TTK inhibitors: CFI-402257 is a potent, selective, bioavailable anticancer agent, ACS Med. Chem. Lett., 7, 671, 10.1021/acsmedchemlett.5b00485 Schoffski, 2022, First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours, Eur. J. Cancer, 169, 135, 10.1016/j.ejca.2022.04.001 Zaman, 2017, TTK Inhibitors as a targeted therapy for CTNNB1 (beta-catenin) mutant cancers, Mol. Cancer Therapeut., 16, 2609, 10.1158/1535-7163.MCT-17-0342 Wang, 2019, Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: a Medicinal chemistry perspective, Eur. J. Med. Chem., 175, 247, 10.1016/j.ejmech.2019.04.047 Uitdehaag, 2017, Target residence time-guided optimization on TTK kinase results in inhibitors with potent anti-proliferative activity, J. Mol. Biol., 429, 2211, 10.1016/j.jmb.2017.05.014 Golding, 2018, The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC), Mol. Cancer, 17, 52, 10.1186/s12943-018-0810-4 Daver, 2019, Targeting FLT3 mutations in AML: review of current knowledge and evidence, Leukemia, 33, 299, 10.1038/s41375-018-0357-9 Szymiczek, 2017, Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma, Oncogene, 36, 6501, 10.1038/onc.2017.266 Sharma, 2012, Histone H2AX phosphorylation: a marker for DNA damage, Methods Mol. Biol., 920, 613, 10.1007/978-1-61779-998-3_40